Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 6905 results found since Jan 2013.
The effect of COVID-19 home quarantine on the psychological state of pharmacy students: a cross-sectional study
ConclusionsStudents ’ psychological depression causes morbidity and, in some cases, mortality. Psychological depressive problems were significantly associated with the COVID-19 home quarantine period, which calls for early intervention to solve it. Student counselling services must be more accessible and affordable t o overcome this problem.
Source: Journal of Pharmaceutical Policy and Practice - November 4, 2022 Category: Pharmaceuticals Source Type: research
Moderna tumbles after slashing forecast for Covid vaccine sales
Coronavirus jab maker ties weaker revenue outlook to delivery delays and supply chain snags
Source: FT.com - Drugs and Healthcare - November 3, 2022 Category: Pharmaceuticals Source Type: news
Vaccine Targeting Both Flu And Covid Starts Trials —As Scientists Test New Ways To Immunize People More Efficiently
The shot combines Pfizer ’s experimental flu vaccine and the companies’ jointly-produced Covid shot targeting BA.4 and BA.5 omicron variants.
Source: Forbes.com Healthcare News - November 3, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news Coronavirus Source Type: news
Emerging employee needs drive major innovation in whole health benefits
From the outset of the coronavirus pandemic, supplemental benefits had an opportunity to prove their value. Thanks to the swift action of health plans and employers, they delivered — making over-the-counter (OTC) medications, essential goods and even healthy foods available to individuals struggling to access needed supplies to stay well during a difficult time.
In many ways, the pandemic represents a seminal moment for these benefits. Employers have new opportunities to e xpand these offerings…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2022 Category: Pharmaceuticals Authors: FirstLine Benefits Source Type: news
InnovationRx: Healthcare ’s 2023 Outlook, Covid Hospitalizations Are Rising And What To Know About RSV
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - November 3, 2022 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Science /science Venture Capital /venture-capital Coronavirus Editors' Pick editors-pick Newsletter No Paywall no-paywall Source Type: news
Chinese stocks boosted by planned rollout of CanSino’s inhalable Covid vaccine
Market rallies on hopes of looser coronavirus lockdown measures and travel restrictions
Source: FT.com - Drugs and Healthcare - November 2, 2022 Category: Pharmaceuticals Source Type: news
Pfizer lifts revenue outlook as Covid jab price rise boosts sales
US drugmaker’s coronavirus vaccine has almost doubled in price since its launch in 2020
Source: FT.com - Drugs and Healthcare - November 1, 2022 Category: Pharmaceuticals Source Type: news
Infant SARS-CoV-2 Infection Uncommon After In Utero Exposure
TUESDAY, Nov. 1, 2022 -- The incidence rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hospitalization, and mortality are low for infants exposed to SARS-CoV-2 infection during pregnancy, according to a study...
Source: Drugs.com - Pharma News - November 1, 2022 Category: Pharmaceuticals Source Type: news
Pfizer Will Raise The Price Of Its Covid-19 Vaccine Almost Fourfold – Reveals Unique Feature Of U.S. Healthcare Pricing
Pfizer plans to charge $110 to $130 for its Covid-19 vaccine dose, almost quadrupling the current price, once the federal government relinquishes its role as dominant purchaser. Evidently, part of this transition consists of raising prices to further boost revenues and profits of vaccine makers.
Source: Forbes.com Healthcare News - November 1, 2022 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus Editors' Pick editors-pick business pharma & Source Type: news
Guests Trapped In Disney On Halloween As China Locks Down Theme Park Over Covid Scare
The Shanghai Disneyland lockdown comes as Foxconn workers reportedly fled restrictions at the firm ’s large iPhone factory.
Source: Forbes.com Healthcare News - October 31, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Lifestyle /lifestyle Travel /travel Breaking breaking-news Coronavirus Source Type: news
Around 6% Of People Have Long Covid Symptoms Post Infection
Long Covid symptoms commonly include chronic fatigue, body pain, mood swings, cognitive problems or brain fog, and ongoing respiratory issues.
Source: Forbes.com Healthcare News - October 31, 2022 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus Source Type: news
New insights on antibody responses to Omicron variants
Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research question. The answers could guide strategies to continue to subdue the COVID pandemic, even as the coronavirus regains ground.
Source: World Pharma News - October 31, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Senate GOP Report Claims Covid-19 Origin A ‘Research-Related Incident,’ Is It All Politics?
The report from the office of Richard Burr (R-NC) claimed that "the COVID-19 pandemic was, more likely than not, the result of a research-related incident." But what evidence did the report actually provide?
Source: Forbes.com Healthcare News - October 30, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Coronavirus business pharma Source Type: news
RSV Infections Are Spiking Among Kids And Swamping Children ’s Hospitals — Here’s What Parents Need To Know
Though RSV infections typically cause mild cold-like symptoms and go away on their own after a few weeks, the virus is potentially lethal for very young children and it is one of the world ’s biggest infant killers.
Source: Forbes.com Healthcare News - October 28, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
